Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease

Documenti analoghi

• Nanoparticle Delivery of Antisense Oligonucleotides and Their Application in the Exon Skipping Strategy for Duchenne Muscular Dystrophy
  di: Falzarano, Maria Sofia, et al.
  Pubblicazione: (2014)
• Recent Advances in Antisense Oligonucleotide Therapy in Genetic Neuromuscular Diseases
  di: Verma, Ashok
  Pubblicazione: (2018)
• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  di: Haiyan Zhou, et al.
  Pubblicazione: (2020-10-01)
• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  di: Zhou, Haiyan, et al.
  Pubblicazione: (2020)
• Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
  di: Catapano, Francesco, et al.
  Pubblicazione: (2016)